EUVIMEDEUVIMED entdecken
Systematische Übersicht

KCTD7 ‐related progressive myoclonic epilepsy: Report of 42 cases and review of literature

Sangeetha Yoganathan, Robyn Whitney iD, Maya Thomas, Sumita Danda, Akbar Mohamed Chettali, Asuri N Prasad, Sali M K Farhan, Daad AlSowat, Musaad Abukhaled, Hesham Aldhalaan, Vykuntaraju K Gowda, Uddhava V Kinhal und 21 weitere

Epilepsia · 2024

DOI: 10.1111/epi.17880 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Epilepsia, 2024. Verfasst von Sangeetha Yoganathan und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Sciences, Christian Medical College, Vellore, Tamil Nadu, India. Hauptthemen laut MEDLINE: Epilepsies, Myoclonic, Myoclonic Epilepsies, Progressive, Unverricht-Lundborg Syndrome. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

KCTD7 ‐related progressive myoclonic epilepsy (PME) is a rare autosomal‐recessive disorder. This study aimed to describe the clinical details and genetic variants in a large international cohort.

Methods

Families with molecularly confirmed diagnoses of KCTD7 ‐related PME were identified through international collaboration. Furthermore, a systematic review was done to identify previously reported cases. Salient demographic, epilepsy, treatment, genetic testing, electroencephalographic (EEG), and imaging‐related variables were collected and summarized.

Results

Forty‐two patients (36 families) were included. The median age at first seizure was 14 months (interquartile range = 11.75–22.5). Myoclonic seizures were frequently the first seizure type noted ( n = 18, 43.9%). EEG and brain magnetic resonance imaging findings were variable. Many patients exhibited delayed development with subsequent progressive regression ( n = 16, 38.1%). Twenty‐one cases with genetic testing available (55%) had previously reported variants in KCTD 7, and 17 cases (45%) had novel variants in KCTD7 gene. Six patients died in the cohort (age range = 1.5–21 years). The systematic review identified 23 eligible studies and further identified 59 previously reported cases of KCTD7 ‐related disorders from the literature. The phenotype for the majority of the reported cases was consistent with a PME ( n = 52, 88%). Other reported phenotypes in the literature included opsoclonus myoclonus ataxia syndrome ( n = 2), myoclonus dystonia ( n = 2), and neuronal ceroid lipofuscinosis ( n = 3). Eight published cases died over time (14%, age range = 3–18 years). Significance This study cohort and systematic review consolidated the phenotypic spectrum and natural history of KCTD7 ‐related disorders. Early onset drug‐resistant epilepsy, relentless neuroregression, and severe neurological sequalae were common. Better understanding of the natural history may help future clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsies, MyoclonicMyoclonic Epilepsies, ProgressiveUnverricht-Lundborg SyndromeAdolescentChildChild, PreschoolHumansInfantYoung AdultElectroencephalographyPotassium ChannelsSeizures

Stichwörter der Autor:innen

CLN14epileptic encephalopathyneurodegenerativeneuronal ceroid lipofuscinosisopsoclonusprogressive myoclonic epilepsy

Substanzen

KCTD7 protein, humanPotassium Channels

Autor:innen und Institutionen

  • Department of Neurological Sciences, Christian Medical College, Vellore, Tamil Nadu, India.
  • Comprehensive Pediatric Epilepsy Program, Division of Neurology, Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
  • Department of Medical Genetics, Christian Medical College, Vellore, Tamil Nadu, India.
  • Department of Child Health, Royal Hospital, Muscat, Sultanate of Oman.
  • Division of Pediatric Neurology and Clinical Neurosciences, Department of Pediatrics, Children's Hospital, London Health Sciences Centre, London, Ontario, Canada.
  • Department of Neurology and Neurosurgery, and Department of Human Genetics, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Robyn Whitney, Ramesh Konanki, Juan P Appendino, Aristides Hadjinicolaou, Mahesh Kamate, Ramshekhar N Menon, Vivek Jain, Elizabeth J Donner, Puneet Jain

Zitieren

APA

Yoganathan, S., Whitney, R., Thomas, M., Danda, S., Chettali, A. M., Prasad, A. N., Farhan, S. M. K., AlSowat, D., Abukhaled, M., Aldhalaan, H., Gowda, V. K., Kinhal, U. V., Bylappa, A. Y., Konanki, R., Lingappa, L., Parchuri, B. M., Appendino, J. P., Scantlebury, M. H., Cunningham, J., …, & Jain, P. (2024). KCTD7 ‐related progressive myoclonic epilepsy: Report of 42 cases and review of literature. Epilepsia. https://doi.org/10.1111/epi.17880

Vancouver

Yoganathan S, Whitney R, Thomas M, Danda S, Chettali AM, Prasad AN, et al. KCTD7 ‐related progressive myoclonic epilepsy: Report of 42 cases and review of literature. Epilepsia. 2024. doi:10.1111/epi.17880

BibTeX
@article{Yoganathan2024,
  author = {Yoganathan, Sangeetha and Whitney, Robyn and Thomas, Maya and Danda, Sumita and Chettali, Akbar Mohamed and Prasad, Asuri N and Farhan, Sali M K and AlSowat, Daad and Abukhaled, Musaad and Aldhalaan, Hesham and Gowda, Vykuntaraju K and Kinhal, Uddhava V and Bylappa, Arun Y and Konanki, Ramesh and Lingappa, Lokesh and Parchuri, Bindu Madhavi and Appendino, Juan P and Scantlebury, Morris H and Cunningham, Jessie and Hadjinicolaou, Aristides and El Achkar, Christelle Moufawad and Kamate, Mahesh and Menon, Ramshekhar N and Jose, Manna and Riordan, Gillian and Kannan, Lakshminarayanan and Jain, Vivek and Manokaran, Ranjith Kumar and Chau, Vann and Donner, Elizabeth J and Costain, Gregory and Minassian, Berge A and Jain, Puneet},
  title = {KCTD7 ‐related progressive myoclonic epilepsy: Report of 42 cases and review of literature},
  journal = {Epilepsia},
  year = {2024},
  doi = {10.1111/epi.17880}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche